Avinger Inc (AVGR)
$1.02
+0.07
(+7.77%)▲
Performance
- $0.97$1.03$1.02
5.29%
Downside
Day's Volatility :5.76%
Upside
0.49%
- $0.90$14.00$1.02
11.76%
Downside
52 Weeks Volatility :93.57%
Upside
92.71%
Returns
| Period | Avinger Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -47.95% | 0.0% |
6 Months | -69.09% | 0.0% |
1 Year | -84.37% | 0.0% |
3 Years | -99.61% | -22.3% |
Highlights
Market Capitalization | 2.2M |
Book Value | $4.05 |
Earnings Per Share (EPS) | -9.19 |
PEG Ratio | 0.0 |
Wall Street Target Price | 5.0 |
Profit Margin | -260.86% |
Operating Margin TTM | -223.44% |
Return On Assets TTM | -65.22% |
Return On Equity TTM | -3332.59% |
Revenue TTM | 7.4M |
Revenue Per Share TTM | 3.88 |
Quarterly Revenue Growth YOY | -9.5% |
Gross Profit TTM | 2.7M |
EBITDA | -17.5M |
Diluted Eps TTM | -9.19 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -4.69 |
EPS Estimate Next Year | -1.18 |
EPS Estimate Current Quarter | -0.43 |
EPS Estimate Next Quarter | -0.42 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 390.2%
Technicals Summary
Sell
Neutral
Buy
Avinger Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Avinger Inc | -17.07% | -69.09% | -84.37% | -99.61% | -99.7% |
 Intuitive Surgical, Inc. | 5.02% | 20.15% | 58.74% | 31.28% | 184.98% |
 Resmed Inc. | 16.09% | 27.14% | 62.7% | -17.28% | 81.24% |
 Becton, Dickinson And Company | 0.02% | -2.08% | -12.88% | -9.76% | -9.75% |
 West Pharmaceutical Services Inc | 1.18% | -17.93% | -26.4% | -35.64% | 104.36% |
 Alcon Ag | 3.83% | 8.9% | 15.02% | 11.44% | 61.54% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Avinger Inc | NA | NA | 0.0 | -4.69 | -33.33 | -0.65 | NA | 4.05 |
Intuitive Surgical, Inc. | 81.91 | 81.91 | 4.06 | 6.65 | 0.16 | 0.08 | NA | 41.4 |
Resmed Inc. | 35.33 | 35.33 | 2.05 | 7.71 | 0.23 | 0.13 | 0.01 | 33.11 |
Becton, Dickinson And Company | 46.72 | 46.72 | 1.08 | 13.11 | 0.06 | 0.03 | 0.02 | 89.5 |
West Pharmaceutical Services Inc | 42.71 | 42.71 | 5.15 | 6.51 | 0.2 | 0.11 | 0.0 | 35.49 |
Alcon Ag | 42.64 | 42.64 | 3.53 | 3.05 | 0.05 | 0.03 | 0.0 | 42.35 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Avinger Inc | Buy | $2.2M | -99.7% | NA | -260.86% |
Intuitive Surgical, Inc. | Buy | $169.4B | 184.98% | 81.91 | 27.65% |
Resmed Inc. | Buy | $36.0B | 81.24% | 35.33 | 21.79% |
Becton, Dickinson And Company | Buy | $67.4B | -9.75% | 46.72 | 7.13% |
West Pharmaceutical Services Inc | Buy | $21.8B | 104.36% | 42.71 | 18.25% |
Alcon Ag | Buy | $46.7B | 61.54% | 42.64 | 11.44% |
Insights on Avinger Inc
Decreasing Revenue
Revenue is down for the last 3 quarters, 1.90M → 1.84M (in $), with an average decrease of 1.6% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -5.51M → -4.36M (in $), with an average increase of 26.5% per quarter
Vs RMD
In the last 1 year, Resmed Inc. has given 62.7% return, outperforming this stock by 147.1%
Vs ISRG
In the last 3 years, Avinger Inc has experienced a drawdown of -99.6%, however Intuitive Surgical, Inc. resisted the overall trend and outperformed by 82.3%
Institutional Holdings
Armistice Capital, LLC
2.28%Vanguard Group Inc
1.24%BlackRock Inc
0.29%Tower Research Capital LLC
0.05%Morgan Stanley - Brokerage Accounts
0.01%Citigroup Inc
0.01%
Company Information
avinger, inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (pad). pad is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. the company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. avinger’s current lumivascular products include the lightbox imaging console, the ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or ctos, and pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in pad patients.
Organization | Avinger Inc |
Employees | 71 |
CEO | Mr. Jeffrey M. Soinski |
Industry | Health Technology |
Discover More
A Spac I Acquisition Corp
$1.02
+7.77%
Keyarch Acquisition Corp
$1.02
+7.77%
Connexa Sports Technologies Inc
$1.02
+7.77%
Us Value Etf
$1.02
+7.77%
First Wave Biopharma Inc
$1.02
+7.77%
Global X Msci Next Emerging
$1.02
+7.77%
Fat Projects Acquisition Corp
$1.02
+7.77%
Capital Link Global Fintech
$1.02
+7.77%
Applied Uv Inc
$1.02
+7.77%